» Articles » PMID: 33096697

Feasibility of a Noninvasive Operability Assessment in Chronic Thromboembolic Pulmonary Hypertension Under Real-World Practice

Abstract

This study aimed to evaluate the feasibility of a noninvasive operability assessment of chronic thromboembolic pulmonary hypertension (CTEPH) based on multidetector computed tomographic angiography (MCTA). Up to 176 patients were evaluated from January 2016 to April 2018. Throughout the first phase, the initial surgical decision was made based on MCTA with further analysis of pulmonary angiography (PA) in order to evaluate in which cases the initial decision was not modified by PA. During the second phase, PA was limited to patients judged inoperable based on MCTA or those whose assessment was not possible. Patients deemed operable (50%) based on MCTA along the first phase had been adequately classified, as PA did not modify the initial decision in all but one patient. Comparable results were obtained throughout the implementation phase. Regarding operated patients, the decision of operability was based solely on MCTA in 94% of those with level I disease, in 75% with level II, and 54% with level III. This approach enabled shorter periods of time to complete surgical assessment and the avoidance of PA-related morbidity. Baseline parameters, postoperative measures, and survival rates at 1 year after surgery were comparable in both phases. Noninvasive operability assessment is feasible in a subset of CTEPH patients and optimizes surgical candidacy evaluation.

Citing Articles

Dual-Energy CT Pulmonary Angiography for the Assessment of Surgical Accessibility in Patients with Chronic Thromboembolic Pulmonary Hypertension.

Eberhard M, McInnis M, de Perrot M, Lichtblau M, Ulrich S, Inci I Diagnostics (Basel). 2022; 12(2).

PMID: 35204319 PMC: 8870807. DOI: 10.3390/diagnostics12020228.


Sex Differences in Chronic Thromboembolic Pulmonary Hypertension. Treatment Options over Time in a National Referral Center.

Cruz-Utrilla A, Cristo-Ropero M, Calderon-Flores M, Velazquez M, Lopez-Gude M, Revilla Ostolaza Y J Clin Med. 2021; 10(18).

PMID: 34575363 PMC: 8466098. DOI: 10.3390/jcm10184251.


Pulmonary Hypertension: Diagnosis and Management.

Torbicki A Diagnostics (Basel). 2021; 11(6).

PMID: 34207897 PMC: 8229206. DOI: 10.3390/diagnostics11061066.


Computed tomography angiographic parameters of pulmonary artery as prognostic factors of residual pulmonary hypertension after pulmonary endarterectomy.

Niznansky M, Kavan J, Zemankova P, Prskavec T, Ambroz D, Jansa P J Int Med Res. 2021; 49(3):3000605211002024.

PMID: 33761801 PMC: 8166393. DOI: 10.1177/03000605211002024.

References
1.
Riedel M, Stanek V, Widimsky J, PREROVSKY I . Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest. 1982; 81(2):151-8. DOI: 10.1378/chest.81.2.151. View

2.
Gall H, Felix J, Schneck F, Milger K, Sommer N, Voswinckel R . The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups. J Heart Lung Transplant. 2017; 36(9):957-967. DOI: 10.1016/j.healun.2017.02.016. View

3.
Cannon J, Su L, Kiely D, Page K, Toshner M, Swietlik E . Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort. Circulation. 2016; 133(18):1761-71. PMC: 5860739. DOI: 10.1161/CIRCULATIONAHA.115.019470. View

4.
Reichelt A, Hoeper M, Galanski M, Keberle M . Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angiography. Eur J Radiol. 2008; 71(1):49-54. DOI: 10.1016/j.ejrad.2008.03.016. View

5.
Gude M, de la Sota E, Vela J, Centeno Rodriguez J, Munoz Guijosa C, Velazquez M . Pulmonary endarterectomy outputs in chronic thromboembolic pulmonary hypertension. Med Clin (Barc). 2017; 149(1):1-8. DOI: 10.1016/j.medcli.2016.12.032. View